Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
2.65B | 3.55B | 3.33B | 2.60B | 2.54B | Gross Profit |
1.31B | 1.93B | 1.70B | 1.17B | 1.09B | EBIT |
152.47M | 770.92M | 704.12M | 198.44M | 61.12M | EBITDA |
392.66M | 1.01B | 853.33M | 286.51M | 177.20M | Net Income Common Stockholders |
175.18M | 614.78M | 516.32M | 126.60M | 45.33M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
3.63B | 3.81B | 3.92B | 3.34B | 3.47B | Total Assets |
6.05B | 6.44B | 6.02B | 5.50B | 5.32B | Total Debt |
392.83M | 382.83M | 302.83M | 331.94M | 354.50M | Net Debt |
-3.24B | -3.43B | -3.61B | -3.01B | -3.11B | Total Liabilities |
1.15B | 1.36B | 1.26B | 1.13B | 950.27M | Stockholders Equity |
4.89B | 5.09B | 4.76B | 4.37B | 4.37B |
Cash Flow | Free Cash Flow | |||
120.93M | 54.88M | 709.30M | 54.88M | 67.50M | Operating Cash Flow |
244.46M | 362.71M | 832.25M | 97.25M | 127.10M | Investing Cash Flow |
-98.98M | -307.32M | -123.86M | -48.88M | 44.07M | Financing Cash Flow |
-377.56M | -210.71M | -158.66M | -151.84M | -160.74M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
84 Outperform | ¥8.24B | 2.75 | 1.91% | 6.45% | 269.38% | ||
73 Outperform | ¥12.95B | 11.18 | 2.27% | 7.79% | 22.67% | ||
72 Outperform | ¥46.83B | 9.80 | 3.88% | -1.61% | -14.35% | ||
70 Outperform | ¥4.06B | 10.81 | 4.78% | 15.88% | 115.04% | ||
68 Neutral | ¥249.94B | 23.41 | 16.08% | 0.07% | 18.75% | 20.55% | |
62 Neutral | $6.88B | 11.07 | 2.77% | 4.28% | 2.67% | -24.94% |